InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,699.94
(
-0.17%
)
US TECH 100
19,261.20
(
-0.09%
)
Dow Jones
42,011.59
(
-0.44%
)
Brent Oil
77.45
(
-0.46%
)
Bitcoin
60,952.45
(
0.33%
)
Post# of 43375
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

nelskof

Send PM Follow Ignore
Followers 16
Posts 1282
Boards Moderated 0
Alias Born 04/23/2020

nelskof

Re: ohm20 post# 22908

Tuesday, 12/15/2020 5:11:16 PM

Tuesday, December 15, 2020 5:11:16 PM

Post# of 43375
So, your changing the goal posts again? The primary outcome measure of the Lenzilumab trial is "Time to Recovery" for Covid-19. This has been the basis the FDA is awarding EUA. I have no doubt they will be approved.

Obviously, the data being shared with the DOD is significant enough to warrant CRADA & BARDA.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up